Robeco Institutional Asset Management B.V. Abb Vie Inc. Transaction History

Robeco Institutional Asset Management B.V.

  • $50.6 Billion
  • Q1 2025

A detailed history of Robeco Institutional Asset Management B.V. transactions in Abb Vie Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 3,876,732 shares of ABBV stock, worth $756 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares
3,876,732
Previous 3,678,683 5.38%
Holding current value
$756 Million
Previous $654 Million 24.25%
% of portfolio
1.61%
Previous 1.26%

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 23, 2025
BUY
$169.2 - $216.66 $33.5 Million - $42.9 Million
198,049 Added 5.38%
3,876,732 $812 Million
Q4 2024

Jan 22, 2025
BUY
$164.99 - $203.87 $18.6 Million - $23 Million
112,925 Added 3.17%
3,678,683 $654 Million
Q3 2024

Oct 29, 2024
BUY
$163.84 - $199.33 $43 Million - $52.3 Million
262,316 Added 7.94%
3,565,758 $704 Million
Q2 2024

Jul 22, 2024
BUY
$154.79 - $180.76 $4.54 Million - $5.3 Million
29,346 Added 0.9%
3,303,442 $567 Million
Q1 2024

Apr 24, 2024
BUY
$159.82 - $182.1 $176 Million - $201 Million
1,101,089 Added 50.67%
3,274,096 $596 Million
Q4 2023

Feb 14, 2024
BUY
$137.6 - $154.97 $113 Million - $127 Million
821,803 Added 60.82%
2,173,007 $337 Million
Q4 2023

Feb 08, 2024
SELL
$137.6 - $154.97 $24.9 Million - $28.1 Million
-181,086 Reduced 11.82%
1,351,204 $2.17 Billion
Q3 2023

Oct 23, 2023
BUY
$133.59 - $154.65 $2.72 Million - $3.14 Million
20,333 Added 1.34%
1,532,290 $228 Million
Q2 2023

Jul 24, 2023
BUY
$132.51 - $164.9 $1.7 Million - $2.12 Million
12,832 Added 0.86%
1,511,957 $204 Million
Q1 2023

May 03, 2023
SELL
$144.61 - $166.54 $31.6 Million - $36.4 Million
-218,642 Reduced 12.73%
1,499,125 $239 Million
Q4 2022

Feb 06, 2023
SELL
$138.31 - $165.87 $46.5 Million - $55.8 Million
-336,458 Reduced 16.38%
1,717,767 $278 Million
Q3 2022

Dec 01, 2022
SELL
$134.21 - $153.93 $23 Million - $26.4 Million
-171,708 Reduced 7.71%
2,054,225 $276 Million
Q3 2022

Oct 26, 2022
SELL
$134.21 - $153.93 $23 Million - $26.4 Million
-171,708 Reduced 7.71%
2,054,225 $276 Million
Q2 2022

Dec 01, 2022
BUY
$137.62 - $174.96 $39.8 Million - $50.6 Million
289,108 Added 14.93%
2,225,933 $341 Million
Q2 2022

Jul 27, 2022
BUY
$137.62 - $174.96 $39.8 Million - $50.6 Million
289,108 Added 14.93%
2,225,933 $341 Million
Q1 2022

Dec 01, 2022
BUY
$131.98 - $163.75 $117 Million - $145 Million
887,064 Added 84.5%
1,936,825 $314 Million
Q1 2022

Apr 26, 2022
BUY
$131.98 - $163.75 $117 Million - $145 Million
887,064 Added 84.5%
1,936,825 $314 Million
Q4 2021

Dec 01, 2022
BUY
$107.43 - $135.93 $33 Million - $41.8 Million
307,472 Added 41.42%
1,049,761 $142 Million
Q4 2021

Jan 31, 2022
BUY
$107.43 - $135.93 $33 Million - $41.8 Million
307,472 Added 41.42%
1,049,761 $142 Million
Q3 2021

Dec 01, 2022
BUY
$106.4 - $120.78 $70,756 - $80,318
665 Added 0.09%
742,289 $80.1 Million
Q3 2021

Oct 20, 2021
BUY
$106.4 - $120.78 $70,756 - $80,318
665 Added 0.09%
742,289 $80.1 Million
Q2 2021

Dec 01, 2022
SELL
$105.21 - $117.21 $83.8 Million - $93.3 Million
-796,348 Reduced 51.78%
741,624 $83.5 Million
Q2 2021

Jul 28, 2021
SELL
$105.21 - $117.21 $83.8 Million - $93.3 Million
-796,348 Reduced 51.78%
741,624 $83.5 Million
Q1 2021

Dec 01, 2022
SELL
$102.3 - $112.62 $52.8 Million - $58.1 Million
-516,253 Reduced 25.13%
1,537,972 $166 Million
Q1 2021

Apr 23, 2021
SELL
$102.3 - $112.62 $38.6 Million - $42.5 Million
-377,401 Reduced 19.7%
1,537,972 $166 Million
Q4 2020

Dec 01, 2022
SELL
$80.49 - $108.67 $11.2 Million - $15.1 Million
-138,852 Reduced 6.76%
1,915,373 $205 Million
Q4 2020

Jan 28, 2021
SELL
$80.49 - $108.67 $71 Million - $95.8 Million
-881,488 Reduced 31.52%
1,915,373 $205 Million
Q3 2020

Oct 29, 2020
SELL
$85.91 - $100.83 $2.02 Million - $2.38 Million
-23,568 Reduced 0.84%
2,796,861 $245 Million
Q2 2020

Jul 20, 2020
BUY
$73.37 - $98.18 $4.64 Million - $6.21 Million
63,217 Added 2.29%
2,820,429 $277 Million
Q1 2020

Apr 30, 2020
SELL
$64.5 - $97.79 $3.9 Million - $5.92 Million
-60,495 Reduced 2.15%
2,757,212 $210 Million
Q4 2019

Feb 06, 2020
SELL
$72.13 - $90.25 $7.08 Million - $8.86 Million
-98,168 Reduced 3.37%
2,817,707 $249 Million
Q3 2019

Oct 17, 2019
BUY
$62.98 - $75.72 $22.1 Million - $26.6 Million
350,870 Added 13.68%
2,915,875 $221 Million
Q2 2019

Jul 19, 2019
BUY
$65.7 - $83.98 $64.4 Million - $82.3 Million
979,638 Added 61.79%
2,565,005 $187 Million
Q1 2019

May 02, 2019
BUY
$77.14 - $90.79 $21.5 Million - $25.3 Million
278,226 Added 21.29%
1,585,367 $128 Million
Q4 2018

Feb 08, 2019
SELL
$77.85 - $96.01 $8.24 Million - $10.2 Million
-105,891 Reduced 7.49%
1,307,141 $120 Million
Q3 2018

Oct 31, 2018
BUY
$88.91 - $98.84 $126 Million - $140 Million
1,413,032 New
1,413,032 $134 Million
Q3 2018

Oct 25, 2018
SELL
$88.91 - $98.84 $102 Million - $113 Million
-1,143,797 Closed
0 $0
Q2 2018

Jan 19, 2021
BUY
$89.78 - $106.23 $103 Million - $122 Million
1,143,797 New
1,143,797 $106 Million
Q2 2018

Aug 03, 2018
SELL
$89.78 - $106.23 $100 Million - $119 Million
-1,115,661 Closed
0 $0
Q1 2018

May 07, 2018
SELL
$92.01 - $123.21 $5.38 Million - $7.2 Million
-58,444 Reduced 4.98%
1,115,661 $106 Million
Q4 2017

Jan 25, 2018
BUY
$89.56 - $98.21 $22.8 Million - $25 Million
254,587 Added 27.69%
1,174,105 $114 Million
Q3 2017

Oct 17, 2017
BUY
$69.85 - $89.22 $1.56 Million - $1.99 Million
22,264 Added 2.48%
919,518 $81.7 Million
Q2 2017

Aug 08, 2017
SELL
N/A
-66,552 Reduced 6.91%
897,254 $65.1 Million
Q1 2017

Jan 19, 2021
BUY
N/A
963,806
963,806 $62.8 Million

Others Institutions Holding ABBV

# of Institutions
4,184
Shares Held
1.29B
Call Options Held
17.1M
Put Options Held
15.1M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $345B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email